Results 121 to 130 of about 1,464,129 (347)
A Phase II Trial of Stereotactic Body Radiation Therapy for Operable T1N0M0 Non-small Cell Lung Cancer: Japan Clinical Oncology Group (JCOG0403) [PDF]
Y. Nagata +9 more
openalex +1 more source
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira +14 more
wiley +1 more source
Chinese Society of Clinical Oncology, Expert Committee on Non-small Cell Lung Cancer
doaj +1 more source
Palliative Care: From the Perspective of Clinical Oncology
The concept of modern palliative care originated in the 1960s. It has been highly valued by the World Health Organization, and promoted globally with the 'three-step analgesic ladder' as the starting point.
SUN Yan
doaj +1 more source
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian +10 more
wiley +1 more source
Supplementum 274: Abstracts of the Swiss Oncology & Hematology Congress (SOHC)
Swiss Society of Medical Oncology +2 more
doaj +1 more source
Digital twins: a new paradigm in oncology in the era of big data
Recent advancements in health care digitalization opened the collection and availability of big data, whose analysis requires artificial intelligence-based technologies to facilitate the development of predictive tools supporting decision making in ...
L. Mollica +5 more
doaj +1 more source
A comprehensive genomic and proteomic analysis of cervical cancer revealed STK11 and STX3 as a potential biomarkers of chemoradiation resistance. Our study demonstrated EGFR as a therapeutic target, paving the way for precision strategies to overcome treatment failure and the DNA repair pathway as a critical mechanism of resistance.
Janani Sambath +13 more
wiley +1 more source
Review of the “Oncology 2.0” Textbook under the Editorship of Professor Sh.Kh. Gantsev
The textbook “Oncology 2.0” by K.Sh. Gantsev, Sh.R. Kzyrgalia, F.V. Moiseenko, and R.S. Yamidanov, under the editorship of Professor Sh.Kh. Gantsev follows the history of the authors’ publications for more than 20 years, revealing the mechanisms of the ...
I. R. Rakhmatullina
doaj
Supplementum 265: Abstracts of the Swiss Oncology & Hematology Congress (SOHC), November 16-18, 2022
Swiss Society of Medical Oncology +2 more
doaj +1 more source

